The Flavin-Containing Monoooxygenases (FMOs): Genetic Variation and its Consequences for the Metabolism of Therapeutic Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|5|4|292-313

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.4, 2007-12, pp. : 292-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development

By Koukouritaki Sevasti B   Hines Ronald N  

Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. : 807-822

Future Medicine

Access to resources Recommend Favorite

Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives

By Hisamuddin Irfan M   Yang Vincent W  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 635-643

Future Medicine

Access to resources Recommend Favorite

The Role of Flavin-Containing Monooxygenase (FMO) in the Metabolism of Tamoxifen and Other Tertiary Amines

By Krueger Sharon   VanDyke Jonathan   Williams David   Hines Ronald  

Drug Metabolism Reviews, Vol. 38, Iss. 1-2, 2006-05 ,pp. : 139-147

Informa Healthcare

Access to resources Recommend Favorite

Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism

By Cashman John R  

Pharmacogenomics, Vol. 3, Iss. 3, 2002-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite

Human Flavin-Containing Monooxygenase Substrate Specificity and Role in Drug Metabolism

By  

Current Drug Metabolism, Vol. 1, Iss. 2, 2000-09 ,pp. : 181-191

Bentham Science Publishers

Access to resources Recommend Favorite